PTEN is a tumor-suppressor gene that has been shown to be under the regulatory control of a PTEN pseudogene expressed noncoding RNA, PTENpg1. Here, we characterize a previously unidentified PTENpg1-encoded antisense RNA (asRNA), which regulates PTEN transcription and PTEN mRNA stability. We find two PTENpg1 asRNA isoforms, a and b. The a isoform functions in trans, localizes to the PTEN promoter and epigenetically modulates PTEN transcription by the recruitment of DNA methyltransferase 3a and Enhancer of Zeste. In contrast, the b isoform interacts with PTENpg1 through an RNA-RNA pairing interaction, which affects PTEN protein output through changes of PTENpg1 stability and microRNA sponge activity. Disruption of this asRNA-regulated network induces cell-cycle arrest and sensitizes cells to doxorubicin, which suggests a biological function for the respective PTENpg1 expressed asRNAs.
a r t i c l e s
The tumor-suppressor gene phosphatase and tensin homolog (PTEN) is a negative regulator of the PI3K-Akt pathway and is epigenetically silenced in several cancers 1 . The dosage of PTEN expression has been found to correlate with the severity of epithelial cancers 2 , which indicates that a fine-tuned regulation of the PTEN gene is critical for maintaining cellular homeostasis. PTEN expression is posttranscriptionally regulated by the action of a PTEN pseudogene (PTENpg1, also known as PTENp1, PTEN2 and PTENΨ1) 3 . The PTENpg1 is a long noncoding RNA (lncRNA) that sequesters numerous PTEN-targeting microRNAs (miRNAs) by acting as a miRNA sponge. The observed miRNA-sponge effect from overexpressing the 3′ untranslated region (3′ UTR) of the PTENpg1 lncRNA resulted in increased PTEN mRNA stability and increased amounts of PTEN protein, presumably owing to miRNA sequestration away from the PTEN protein-coding transcripts. In contrast, suppression of the PTENpg1 lncRNA released miRNAs, which instead led to destabilization of PTEN.
Expressed pseudogenes are conserved across millions of years of primate evolution 4 and have traditionally been considered 'nonfunctional DNA' that litters the human genome. Pseudogenes are almost as numerous as protein-coding genes 5 , and recent evidence shows some of these to be transcribed into RNA 3, 6 . An emerging paradigm suggests that some pseudogenes may be functional in directly regulating their protein-coding counterparts at either the transcriptional or post-transcriptional level 3, [7] [8] [9] . In contrast to PTENpg1-mediated post-transcriptional regulation of PTEN, the pluripotency-associated transcription factor OCT4 was reported to be under the epigenetic regulation of an antisense RNA (asRNA) to the OCT4 (official symbol POU5F1) pseudogene 5 (ref. 7) .
Taken together, these previous observations encouraged us to investigate whether there is an asRNA also encoded from the PTENpg1 locus and to what extent such an asRNA is involved in regulating the tumor-suppressor gene PTEN.
RESULTS
The PTEN pseudogene PTENpg1 encodes asRNA To investigate the genomic landscape and the presence of asRNA transcription at the PTENpg1 locus, we assessed expressed-sequence-tags (ESTs) in the UCSC genome browser and also carried out an independent analysis of ENCODE chromatin immunoprecipitation (ChIP) sequencing data. The assessment of EST reads indicated asRNA transcription from the PTENpg1 locus ( Supplementary Fig. 1a ). In addition, our analysis of ENCODE ChIP-sequencing data for the presence of the active transcriptional histone mark Lys4 trimethylation of histone H3 (H3K4me3) indicated differential patterns among different cell lines (Supplementary Fig. 1b) . Moreover, analysis of H3K4me3 and RNA polymerase II (RNAPII) localization in human embryonic stem cells (H1-hESC) and K562 cells showed overlap and binding at two different loci, which indicated promoter activity and two different transcriptional start sites (TSSs) at the PTENpg1 locus ( Supplementary Fig. 1b) .
Next, we set out to investigate whether the ChIP-sequencing peaks for H3K4me3 and RNAPII corresponded to the TSSs for the indicated PTENpg1 asRNA transcripts ( Supplementary Fig. 1a,b ). To this end, we carried out analysis by 5′ rapid amplification of cDNA ends (RACE; Supplementary Table 1a ) and primer walk ( Supplementary Fig. 2a,b ). These analyses indicated two different TSSs at the PTENpg1 locus that initiate asRNA transcription. In total, a r t i c l e s three dominant PTENpg1 asRNA isoforms were identified (unspliced, α and β; Fig. 1a, Supplementary Fig. 2a-e and Supplementary  Table 1a ) as well as alternative splicing of PTENpg1 asRNA exon 3 ( Supplementary Fig. 2c and Supplementary Table 1b ). Cellular fractionation showed that the spliced α and β isoforms were expressed at high levels in the cytoplasm, whereas the unspliced PTENpg1 asRNA α isoform was exclusively found in the nuclear fraction ( Supplementary Fig. 2d-e ). Depletion of polyadenylated RNA from total cellular RNA confirmed the spliced α and β isoforms to be poly(A) + , in contrast to the PTENpg1 sense and unspliced PTENpg1 asRNA α isoforms, which were mainly poly(A)-negative transcripts ( Fig. 1b and Supplementary Fig. 2f ).
Characterization of the PTENpg1 asRNA
The dominantly spliced α and β asRNA transcripts appeared to emanate from two different TSSs that notably overlap with the PTENpg1 sense promoter ( Fig. 1a, Supplementary Fig. 2a,b and Supplementary Table 1a ). These regions also appeared functional as divergently transcribed promoters, as determined in luciferase expression assays (Supplementary Fig. 3a-c ). In a screen among different human cell lines, high expression of PTENpg1 asRNA significantly correlated with low expression of PTEN mRNA, on the basis of a Spearman rank correlation analysis ( Fig. 1c and Supplementary Fig.  3d) . Unexpectedly, the opposite correlation was observed for PTENpg1 sense and asRNA, which appeared to be coexpressed ( Fig. 1d and Supplementary Fig. 3d ). The discordant expression between PTEN and PTENpg1 asRNA was further supported by quantitative real-time PCR (qRT-PCR) analysis of a subset of cell lines (Fig. 1e,f) and also by western blot analysis of PTEN protein levels, with the only exception being the PTEN-deleted PC3 prostate cancer cell line ( Supplementary  Fig. 3e ). Furthermore, the absolute expression of PTENpg1 sense and asRNA transcripts was also measured. After cloning the cDNA of each transcript, defined amounts of these cDNA clones were used for standard-curve analysis in qRT-PCR, and the PTENpg1 asRNA was generally expressed at higher copy numbers as compared to the sense counterpart ( Supplementary Fig. 3f ).
PTENpg1 asRNA a is a negative regulator of PTEN expression
The observed discordant expression across disparate cell lines was suggestive of a negative regulatory association between the PTENpg1 asRNA and PTEN mRNA expression. To investigate this notion further, HEK293T cells were transfected with short interfering RNAs (siRNAs) or short hairpin RNAs (shRNAs) targeting the PTENpg1 asRNA α transcript (pg1as α-siRNA and pg1as α-shRNA, respectively; Supplementary Fig. 4a ). Suppression of PTENpg1 asRNA α with these si-or shRNAs resulted in a significant increase in PTEN mRNA expression in HEK293T cells ( Fig. 2a and Supplementary  Fig. 4b,c) . The activation of PTEN did not appear to involve any changes in the levels of the previously reported miRNA spongeacting PTENpg1 (Fig. 2b) . The discordant regulation between PTEN and PTENpg1 asRNA α was further confirmed in the U2OS cell line ( Fig. 2c ) and the HeLa cell line ( Fig. 2d) . Notably, HeLa cells lack detectable levels of PTENpg1 sense ( Supplementary Fig. 3d ), which suggests that PTENpg1 asRNA α functions independently of PTENpg1 sense. The observed induction of PTEN after targeting of the PTENpg1 asRNA α was transcriptional in nature, on the basis of changes in the expression of PTEN pre-mRNA ( Fig. 2a) . The transcriptional activation of PTEN was further supported by run-on analysis ( Fig. 2e) and ChIP for RNAPII binding at the PTEN promoter ( Fig. 2f) . The si-or shRNA constructs targeting the PTENpg1 asRNA α did not affect PTEN expression in HCT116 or MCF7 cells, which do not express appreciable levels of the PTENpg1 asRNA ( Supplementary Fig. 4d-f npg a r t i c l e s similar mechanisms as previously observed for other genes where noncoding RNAs (ncRNA), in particular asRNAs 10, 11 , have been found to have a role in the recruitment of repressive chromatin remodelers such as Enhancer of Zeste (EZH2) 7, 12 , DNA methyltransferase 3A (DNMT3A) 13 and the methyltransferase G9A 7 .
PTENpg1 asRNA a localizes to the PTEN promoter Previous observations implied a regulatory role for asRNAs in epigenetic-based regulation of gene transcription in human cells, but direct evidence supporting this notion has remained enigmatic 7,10,11 . To explore whether the induced expression of PTENpg1 asRNA α could suppress PTEN, we cloned the PTENpg1 asRNA α into GFP-encoding lentiviral vectors, with a U6 promoter driving its expression 14 . Stable Jurkat cell lines with the induced expression of PTENpg1 asRNA α were generated and followed over 40 d (Supplementary Fig. 5a ). Expression of the PTENpg1 asRNA α was verified, and a corresponding suppression of PTEN was observed, which supports the notion that the PTENpg1 asRNA α acts in trans as a negative regulator of PTEN ( Fig. 3a,b) . To further investigate the interaction between PTEN and PTENpg1 asRNA, PTENpg1 asRNA was in vitro transcribed by using fluorinated and biotin-linked nucleotides (Supplementary Fig. 5b ). This modified in vitro transcript was successfully transfected into the target cells and had a half-life greater than 48 h ( Supplementary  Fig. 5c ). The fluorinated and biotin-linked PTENpg1 asRNA also suppressed PTEN expression ( Fig. 3c ) and localized to the PTEN promoter in the MCF7 cells ( Fig. 3d) . Overexpression of PTENpg1 asRNA did not induce any detectable levels of the interferon α-induced genes OAS1 and IL6, which potentially could be triggered by doublestranded RNA formation ( Supplementary Fig. 5d ). Altogether, these data show that PTENpg1 asRNA α localizes to the PTEN promoter and suppresses PTEN mRNA expression.
PTENpg1 asRNA a induces chromatin remodeling
Next, we set out to investigate the molecular mechanisms whereby PTENpg1 asRNA α exerts its regulatory function on PTEN transcription. We investigated the involvement of a subset of previously identified proteins, such as histone deacetylase 1 (HDAC1), Argonaute 1 (AGO1), Argonaute 2 (AGO2), DNMT3A, EZH2 and G9A, on the basis of previous work on transcriptional regulation mediated by ncRNAs 7, 12, 13, [15] [16] [17] . siRNA-induced depletion showed that both EZH2 and DNMT3A appeared to be involved in the regulation of PTEN. The suppression of EZH2 and DNMT3A in cell lines with expression of PTENpg1 asRNA resulted in activation of PTEN ( Fig. 3e and Supplementary Fig. 6a-c) . In contrast, depletion of EZH2 and DNMT3A in the HCT116 cell line, which lacks PTENpg1 asRNA expression ( Supplementary Fig. 4d ), had only a modest effect on PTEN levels ( Supplementary Fig. 6b-d ). In addition, simultaneous depletion of both EZH2 and PTENpg1 asRNA α did not prove additive in two different cell lines with regard to activating PTEN, which further supports the notion that these two factors function in concert ( Supplementary Fig. 6e,f) . These observations led us to investigate whether EZH2 and DNMT3a may directly interact within a protein-RNA complex together with PTENpg1 asRNA α. RNA immunoprecipitation of DNMT3a showed DNMT3a and PTENpg1 asRNA α to coimmunoprecipitate and thus interact within the same protein-RNA complex ( Fig. 3f and Supplementary Table 1c ). Taken together, these data indicate that EZH2 and DNMT3a are involved in the regulation of PTEN expression and, notably, that DNMT3a interacts directly with the PTENpg1 asRNA α transcript.
Previous reports have suggested that DNMT3a and EZH2 interact 16 with one another and regulate levels of transcription by catalyzing the addition of three methyl groups to histone H3 Lys27 (H3K27me3), which forms a negative, repressive chromatin mark 18, 19 . Therefore, we decided to investigate the presence of DNMT3a and EZH2 at the PTEN promoter and whether the PTENpg1 asRNA α actively recruits these factors. To explore this notion, we induced siRNA depletion of PTENpg1 asRNA α and investigated possible changes in the levels of H3K27me3, DNMT3a and EZH2 at the PTEN promoter. The suppression of the PTENpg1 asRNA α variant correlated with a loss of EZH2 and H3K27me3 at the PTEN promoter ( Fig. 3g,h) . In addition, we also set out to target the PTENpg1 asRNA α variant by using single-stranded phosphorothioate oligonucleotides (ODNs) (Supplementary Fig. 4a) . In contrast to siRNAs, ODNs function by the RNase-H pathway, which induces strand-specific targeting of RNA followed by degradation of the RNA-ODN duplex 20 . Notably, the suppression of the PTENpg1 asRNA α variant by using these npg a r t i c l e s ODNs caused a substantial loss of DNMT3a at the PTEN promoter in two different cell lines (Fig. 3i) .
Collectively, these data demonstrate that the PTENpg1 asRNA α binds and recruits the chromatin remodelers DNMT3a and EZH2 to the PTEN promoter and catalyzes the formation of H3K27me3. This led us to investigate whether the endogenous PTENpg1 asRNA α localizes to the PTEN promoter and more specifically to the H3K27me3 chromatin mark. We therefore carried out a modified ChIP protocol for H3K27me3 and analyzed whether the nuclearlocalized PTENpg1 asRNA associated directly with this epigenetic mark. Indeed, endogenous unspliced PTENpg1 asRNA localized to this histone mark (Fig. 3j) .
PTENpg1 asRNA b interacts with PTENpg1 sense
The observation that the PTENpg1 sense lacks a robust poly(A) tail ( Fig. 1b and Supplementary Fig. 2f ) was further validated by 3′ RACE. The cloned 3′ RACE end of PTENpg1 sense was sequenced, revealing the lack of a poly(A) tail ( Supplementary Table 1d ). Notably, poly(A)tailed transcripts have been implicated in RNA stability 21 and transport of RNA from the nucleus to the cytoplasm 22, 23 . Collectively, the lack of poly(A) tails suggested that the PTENpg1 sense might be an unstable transcript that is retained in the nucleus. However, contrary to this notion, blocking transcription by actinomycin-D treatment resulted in similar stability of all three transcripts analyzed; PTENpg1 sense and the poly(A) + transcripts PTEN and PTENpg1 asRNA (Fig. 4a) . Therefore, we surmised that PTENpg1 sense RNA is stabilized by alternative means in the cell. One possible mechanism could involve sense-asRNA interactions, which have previously been reported to modulate RNA stability 24 . That PTENpg1 sense and asRNA are coexpressed among different cell lines ( Fig. 1d and Supplementary  Fig. 3d ) and that they also share a divergently transcribed promoter (Supplementary Fig. 3a-c) suggested that they might be co-regulated and might interact with each other through a double-stranded RNA intermediate. In vitro RNAse-A analysis reaffirmed this notion and indicated that the PTENpg1 sense and asRNA transcripts interact with each other in an RNA-RNA-dependent manner (Fig. 4b) .
To explore this further, we first developed U6-expressed singlestranded RNAs (ssRNAs) targeting the overlap between PTENpg1 sense and asRNA β (Supplementary Fig. 4a) . Notably, interfering with this interaction resulted in a decreased half-life of PTENpg1 sense (Fig. 4c) . Next, single-stranded ODNs specifically targeting the PTENpg1 sense and asRNA β overlap and shRNAs targeting the PTENpg1 asRNA exon 2 and 3 were designed (Supplementary Fig.  4a ). Both of these approaches resulted in a concordant reduction of PTENpg1 sense expression and notably also suppressed PTEN mRNA (Fig. 4d,e ) and protein levels (Fig. 4f) . This observed suppression of PTEN is in line with previous reports, where PTENpg1 sense has been described to bind and sequester miRNAs 3 . More precisely, the RNA-RNA interaction is lost upon depletion of PTENpg1 asRNA β, whereby PTENpg1 sense is destabilized and its expression decreased. Consequently, miRNAs, which are normally bound and sequestered by PTENpg1 sense, may be released and free to bind the PTEN mRNA instead. Taken together, these data suggest that the RNA-RNA interaction between PTENpg1 sense and asRNA β is required for PTENpg1 sense to function as a miRNA sponge. Notably, this also shows that the PTENpg1 asRNA α and β isoforms have different functions; the α isoform regulates PTEN transcription, whereas the β isoform appears to be involved as a We further set out to investigate whether this RNA-RNA interaction occurred in the nucleus or in the cytoplasm. To this end, PTENpg1 asRNA β was knocked down by using shRNA targeting followed by fractionation of cytoplasm and nuclei. The PTENpg1 asRNA β shRNA targeting resulted in a reduction in PTENpg1 sense levels exclusively in the cytoplasm, whereas the levels were unaffected in the nucleus (Fig. 4g) . In summary, these data suggest that the PTENpg1 sense-asRNA β interaction is required for maintaining stable levels of PTENpg1 sense in the cytoplasm and ultimately PTENpg1 sense sponge activity.
PTENpg1 asRNA a regulates the cell cycle and apoptosis
The mechanistic studies presented here suggest a regulatory interaction between PTEN, PTENpg1 sense and PTENpg1 asRNA. Because perturbations of PTENpg1 asRNA α levels markedly affected PTEN mRNA expression, we decided to investigate the effects of disrupting this lncRNA network on PTEN protein expression. Western blot analysis following siRNA depletion of PTENpg1 asRNA α resulted in a clear induction of PTEN protein levels at several time points in various cell lines (Fig. 5a) . Furthermore, the elevated PTEN protein a r t i c l e s levels lead to a concomitant downregulation of the PTEN downstream target pAKT (Fig. 5b) . Because PTEN is a negative regulator of the cell cycle, we studied the effect on the CDK inhibitor p21 following depletion of PTENpg1 asRNA α. Depletion of PTENpg1 asRNA α resulted in a marked induction of p21, both 48 h and 96 h after transfection (Fig. 5b) 25 . Notably, p21 was not induced upon PTENpg1 asRNA α depletion in cell lines lacking expression of PTENpg1 asRNA α, which argues against off-target effects of the siRNA (Supplementary Fig. 6g ). More specifically, PTEN-dependent induction of p21 was verified by simultaneous siRNA depletion of PTEN and PTENpg1 asRNA α, which did not result in an induction of p21 protein expression ( Fig. 5c) . This negative effect on the cell cycle was further supported by fluorescence-activated cell sorting (FACS) analysis (Fig. 5d) , which demonstrated a significant G0-G1 arrest in the PTENpg1 asRNA α-suppressed U2OS cells. In contrast, simultaneous depletion of PTEN and PTENpg1 asRNA α partially rescued the G0-G1 cell cycle arrest (Fig. 5e) . Apart from causing a negative cell-cycle effect, PTEN levels are also important in regulating apoptosis sensitivity 26 . Suppression of PTENpg1 asRNA α caused a modest effect on the basal levels of cell death but clearly sensitized cells to the DNA-damaging agent doxorubicin ( Fig. 5f) . Together, these data suggest that the regulatory impact of PTENpg1 asRNA α on PTEN expression is physiologically relevant and may function in the sensitization of tumor cells to chemotherapeutic treatments, such as doxorubicin.
DISCUSSION
The data presented here argue for a more complex role for lncRNAs in human cellular gene regulation than had previously been appreciated. We find here that lncRNAs can form higher-ordered biologically relevant functional structures through RNA-protein as well as RNA-RNA interactions. Earlier studies have reported that PTENpg1 sense lncRNA functions as a miRNA sponge, an interaction that has typically been thought to occur in the cytoplasm 3, 27 . It was suggested that, mechanistically, PTENpg1 sense lncRNA binds the PTEN targeted miRNAs, whereby the miRNA targeting of PTEN is diminished, ultimately resulting in increased PTEN mRNA and protein expression. These previous studies, however, overlooked the presence of PTENpg1-associated asRNA transcripts.
We report here that the PTENpg1 locus expresses mechanistically functional asRNAs and that these transcripts appear to function as major regulators of PTEN expression at both the transcriptional and post-transcriptional levels. Within this body of work, we investigate the three PTEN-regulatory lncRNAs, PTENpg1 sense, PTENpg1 asRNA α and PTENpg1 asRNA β, and observe that these transcripts are expressed from two divergently transcribed promoters (Supplementary Fig. 3a-c) . We find that a complex regulatory network of lncRNAs is operative, whereby PTENpg1 asRNA α physically localizes to the PTEN promoter and directs epigenetic remodeling proteins to control PTEN transcription. In contrast, the PTENpg1 asRNA β transcript forms an RNA-RNA interaction with PTENpg1 sense, altering cellular compartmental distribution of the PTENpg1 sense transcripts, miRNA sequestration and, ultimately, PTEN protein levels (Fig. 6) . Although more complex than previously appreciated, how the transcriptional regulation of the PTENpg1 locus is controlled and whether any regulatory switch or interplay is functional between PTENpg1 asRNA α and PTENpg1 asRNA β still remains unknown. In addition, even though we find the PTENpg1 asRNA α to directly localize at the PTEN promoter and to coimmunoprecipitate with DNMT3a, the details of these interactions remain to be explored.
The observations presented here suggest a model whereby a pseudogene, PTENpg1, contains bimodal functionality that directly and simultaneously affects PTEN transcription and mRNA stability (Fig. 6) . This model, built on RNA-RNA and RNA-protein interactions, might highlight a mechanism whereby organisms lacking an RNA-dependent RNA polymerase (RdRP), such as primates, can use a different paradigm such as pseudogene-expressed lncRNAs to regulate gene expression. A functional RdRP would be expected to result in amplification of these RNA-RNA complexes and ultimately RNA interference-based mechanisms of regulation. However, the lack of a viable RdRP offers increased functional complexities in both the nucleus and cytoplasm, as the lncRNA complexes would not be processed by RdRP but instead function in a different context, such as simultaneously governing both gene transcription and RNA stability, as demonstrated here. Such observations add a significant layer of complexity to our current understanding of gene regulation and highlight a biological role for pseudogene-expressed lncRNAs in human cells. Such a system, as is determined here and illustrated in Figure 6 , The PTENpg1 locus is transcribed in both sense (red) and antisense orientation (blue) (1) . Three different isoforms of the PTENpg1 asRNA are transcribed: PTENpg1 asRNA α, β and the unspliced nuclearlocalized PTENpg1 asRNA α (1-2). PTEN transcription is suppressed by the PTENpg1 asRNA α and unspliced isoforms, which act in trans by recruiting the chromatin-repressor proteins EZH2 and DNMT3A to the PTEN promoter (3). The PTENpg1 sense lacks a poly(A) tail, and the stability and export of PTENpg1 sense to the cytoplasm is facilitated by the interaction with the spliced PTENpg1 asRNA β transcripts (4). Such interactions lead to an increase of PTENpg1 sense sponge activity and thus increased PTEN mRNA stability and translation (5). This mechanism (1-5) results in both transcriptional and post-transcriptional regulation of PTEN by its pseudogene. The model indicates a level of synchronization between the pseudogene and its protein-coding counterpart.
provides for a useful cellular adaptation strategy that allows for fine control and balance of the output of PTEN proteins, ultimately resulting in control of cell growth. It also invites speculation about whether the PTENpg1 asRNA α could act as a ncRNA oncogene, owing to its negative regulatory effect on PTEN. In future studies, it would be fruitful to profile human cancer tumors with diminished PTEN expression and investigate whether increased expression of PTENpg1 asRNA could promote epigenetic silencing of PTEN and tumor development. If so, knowledge of this PTENpg1 and other pseudogene ncRNA regulatory pathways may prove useful in therapeutically relevant approaches to controlling gene expression as well as informative with regard to tumor biology.
METHODS
Methods and any associated references are available in the online version of the paper. Lentiviral production, transduction and selection. Lentiviral particles were produced and titrated as previously described 35 . Jurkat cells were infected at a multiplicity of infection = 1 by spinoculation for 30 min. Transduced cells were placed under selection with 1-2 µM mycophenolic acid (Sigma-Aldrich) for 20 d.
Generation of biotin-linked PTENpg1 asRNAs. PTENpg1 asRNA α was PCR amplified by using primers with Nhe1 or Kpn1 restriction sites (Supplementary Table 2 ) and cloned into pcDNA 3.1. T7 transcripts were generated by linearization of pcDNA 3.1 with Kpn1 and T7 transcribed with the Durascribe T7 kit (Epicenter) using fluorinated CTPs and UTPs (TriLink). Biotin-UTPs were incorporated at a ratio of 1:10. The resultant transcripts were DNase treated and dephosporylated by using Antarctic phosphatase (New England BioLabs). Transcripts were precipitated by using phenol-chloroform and EtOH precipitation. The T7 transcripts were transfected into target cells at 25-50 nM by using Lipofectamine 2000 (Life Technologies). For in vivo pulldown, MCF7 cells were transfected and collected 30 h later, and avidin IPs were performed as described 32, 33 .
PI-annexin V staining. Treated cells were harvested, washed in PBS, pelleted and resuspended in 100 µL annexin V incubation buffer (10 mM HEPES/ NaOH, pH 7.4, 140 mM NaCl, 5 mM CaCl 2 ) containing 1% annexin V FLOUS (Roche Molecular Biochemicals) and 500 µg/µl PI stain. The samples were incubated for 15 min followed by the addition of 400 µl of annexin V incubation buffer and subsequently analyzed on a cytometry machine using the Cell Quest software.
Cell-cycle distribution. Cells were washed in PBS and fixed in 4% PFA at room temperature overnight. PFA was removed, and cells were resuspended in 95%
EtOH. The samples were then rehydrated in distilled water, stained with DAPI and analyzed by flow cytometry on a FACSCalibur (Becton Dickinson) using Cell Quest software.
ODN targeting of PTENpg1 asRNA transcripts. The ODNs (IDT) were produced and transfected at 100 nM by using RNAiMax (Life Technologies).
